Dublin, Ireland April 01 - April 04, 2019
The 2019 ISPE Europe Annual Conference will focus on four core areas that continue to drive, challenge, and shape pharma manufacturing:
- Facilities of the Future
- Pharma 4.0 & Implementation in Pharmaceutical Operations
- Quality Risk Management, Process Validation, Continuous Process Verification, and GAMP®
- Project Management and Engineering
Visit us to hear about our Biopharmaceutical solutions, including our; GMP washers, sterilizers, closure processing systems, isolators and sterile transfer systems to meet each facility’s specific needs.
Date: April 01 - April 04, 2019
City: Dublin, Ireland
Venue: Clayton Hotel Burlington Road
Striving for the highest quality outcome from production processes
Biopharmaceutical production facilities are acutely concerned with maximizing uptime and performance while safeguarding against microbial and particulate contamination. Contamination can influence a drug’s active ingredient, excipient potency or its administered use, such as injection or infusion. Contamination can also negatively affect the patient’s health.
Our Biopharmaceutical solutions
Products manufactured by the biopharmaceutical industry serve as the first and last lines of defense in patient care. Manufacturers require maximum uptime, service and protection against microbial and particulate contamination in order to ensure the efficiency of life-saving medicinal products produced from chemical and biological sources.
Transfer material without breaking containment
The patented DPTE® transfer system enables the user to transfer toxic or aseptic components without breaking containment. The DPTE® system is based on the interaction of two separate units – "Alpha" and "Beta" – each fitted with a door, a lock and a sealing function.
Meeting GMP requirements in Terminal Sterilization
GMP regulations require that if a product can be terminally sterilized — without affecting the quality, safety or efficacy of the packaged products — it must be. Getinge sterilizers are designed to meet rigorous sterilization challenges of the most complex drug delivery systems.
Getinge barrier isolation prevents product contamination and protects operators in aseptic filling processes. Isolator technology reduces the need for sterile conditions to the smallest possible working volume while allowing operation to take place in a class D clean room.